Associations between prediagnostic aspirin use and ovarian tumor gene expression
Abstract
Aspirin use has been associated with reduced ovarian cancer risk, yet the underlying biological mechanisms are not fully understood. To gain mechanistic insights, we assessed the association between prediagnosis low and regular‐dose aspirin use and gene expression profiles in ovarian tumors.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 01, 2023
- Source ID
- 10.1002/cam4.6386
Entities
People
- Brooke L. Fridley
- John L. Cleveland
- Jonathan L Hecht
- Jose Conejo‐garcia
- Kathryn L. Terry
- Naoko Sasamoto
- Paul A Stewart
- Sean J. Yoder
- Shelley S. Tworoger
- Tianyi Wang
- Zachary J. Thompson
Organizations
- H. Lee Moffitt Cancer Center & Research Institute
- Harvard Medical School
- Harvard University
- National Cancer Institute
- Rivkin Center for Ovarian Cancer
- United States Department of Defense